A Feasibility Study of the Nativis Voyager System in Patients with Recurrent Glioblastoma Multiforme (rGBM). This study is currently recruiting patients.
Abstract presented by Xavier Figueroa, PhD, at Society for Neuro-Oncology 2016 Annual Conference, Scottsdale, AZ on November 19, 2016.
The latest information on publications highlighting Nativis research and advancements.
May 26, 2017
Non-Thermal Radio Frequency Stimulation Inhibits the Tryptophan Synthase Beta Subunit in the Algae Chlamydomonas reinhardtii
Non-Thermal Radio Frequency Stimulation of Tubulin Polymerization In Vitro: A Potential Therapy For Cancer Treatment
May 18, 2017
Nativis Expands C-Suite with the Addition of Dr. Kenneth Ferguson as Chief Scientific Officer
Nativis Voyager® ulRFE™ System for rGBM is an investigational medical device. Limited by Federal (or United States) law to investigational use only.
© Nativis 2015 - 2017